| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 4 |
| NetGPI | no | yes: 0, no: 4 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0016020 | membrane | 2 | 4 |
| GO:0110165 | cellular anatomical entity | 1 | 4 |
Related structures:
AlphaFold database: E9AS00
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 12 | 14 | PF00675 | 0.732 |
| CLV_NRD_NRD_1 | 142 | 144 | PF00675 | 0.551 |
| CLV_NRD_NRD_1 | 160 | 162 | PF00675 | 0.353 |
| CLV_NRD_NRD_1 | 168 | 170 | PF00675 | 0.492 |
| CLV_PCSK_KEX2_1 | 11 | 13 | PF00082 | 0.752 |
| CLV_PCSK_KEX2_1 | 110 | 112 | PF00082 | 0.632 |
| CLV_PCSK_KEX2_1 | 142 | 144 | PF00082 | 0.551 |
| CLV_PCSK_KEX2_1 | 160 | 162 | PF00082 | 0.353 |
| CLV_PCSK_KEX2_1 | 168 | 170 | PF00082 | 0.492 |
| CLV_PCSK_PC1ET2_1 | 110 | 112 | PF00082 | 0.632 |
| CLV_PCSK_SKI1_1 | 110 | 114 | PF00082 | 0.632 |
| CLV_PCSK_SKI1_1 | 160 | 164 | PF00082 | 0.562 |
| CLV_PCSK_SKI1_1 | 29 | 33 | PF00082 | 0.589 |
| CLV_PCSK_SKI1_1 | 82 | 86 | PF00082 | 0.724 |
| DEG_APCC_DBOX_1 | 159 | 167 | PF00400 | 0.762 |
| DEG_SPOP_SBC_1 | 18 | 22 | PF00917 | 0.625 |
| DOC_CYCLIN_RxL_1 | 107 | 117 | PF00134 | 0.432 |
| DOC_MAPK_gen_1 | 160 | 167 | PF00069 | 0.566 |
| DOC_MAPK_gen_1 | 29 | 38 | PF00069 | 0.361 |
| DOC_MAPK_MEF2A_6 | 160 | 167 | PF00069 | 0.566 |
| DOC_MAPK_MEF2A_6 | 65 | 74 | PF00069 | 0.339 |
| DOC_MAPK_NFAT4_5 | 160 | 168 | PF00069 | 0.569 |
| DOC_MAPK_NFAT4_5 | 65 | 73 | PF00069 | 0.339 |
| DOC_MAPK_RevD_3 | 145 | 161 | PF00069 | 0.766 |
| DOC_PP2B_LxvP_1 | 60 | 63 | PF13499 | 0.546 |
| DOC_USP7_MATH_1 | 27 | 31 | PF00917 | 0.389 |
| LIG_14-3-3_CanoR_1 | 168 | 172 | PF00244 | 0.787 |
| LIG_14-3-3_CanoR_1 | 23 | 31 | PF00244 | 0.508 |
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.441 |
| LIG_FHA_1 | 116 | 122 | PF00498 | 0.524 |
| LIG_LIR_Nem_3 | 81 | 87 | PF02991 | 0.425 |
| LIG_LIR_Nem_3 | 91 | 97 | PF02991 | 0.516 |
| LIG_PDZ_Class_1 | 167 | 172 | PF00595 | 0.783 |
| LIG_Pex14_1 | 98 | 102 | PF04695 | 0.550 |
| LIG_Pex14_2 | 129 | 133 | PF04695 | 0.524 |
| LIG_Pex14_2 | 134 | 138 | PF04695 | 0.443 |
| LIG_RPA_C_Fungi | 138 | 150 | PF08784 | 0.419 |
| LIG_SH2_NCK_1 | 48 | 52 | PF00017 | 0.694 |
| LIG_SH2_PTP2 | 156 | 159 | PF00017 | 0.713 |
| LIG_SH2_STAT5 | 156 | 159 | PF00017 | 0.713 |
| LIG_SH2_STAT5 | 79 | 82 | PF00017 | 0.659 |
| LIG_SH3_3 | 12 | 18 | PF00018 | 0.793 |
| LIG_SUMO_SIM_anti_2 | 58 | 63 | PF11976 | 0.695 |
| LIG_TYR_ITIM | 92 | 97 | PF00017 | 0.665 |
| LIG_WRC_WIRS_1 | 126 | 131 | PF05994 | 0.524 |
| MOD_Cter_Amidation | 140 | 143 | PF01082 | 0.674 |
| MOD_GlcNHglycan | 135 | 138 | PF01048 | 0.524 |
| MOD_GSK3_1 | 19 | 26 | PF00069 | 0.616 |
| MOD_N-GLC_1 | 18 | 23 | PF02516 | 0.523 |
| MOD_NEK2_1 | 125 | 130 | PF00069 | 0.524 |
| MOD_NEK2_1 | 133 | 138 | PF00069 | 0.394 |
| MOD_NEK2_1 | 38 | 43 | PF00069 | 0.696 |
| MOD_NEK2_1 | 78 | 83 | PF00069 | 0.662 |
| MOD_NEK2_2 | 27 | 32 | PF00069 | 0.454 |
| MOD_Plk_4 | 104 | 110 | PF00069 | 0.679 |
| MOD_Plk_4 | 55 | 61 | PF00069 | 0.712 |
| TRG_DiLeu_BaEn_1 | 56 | 61 | PF01217 | 0.718 |
| TRG_DiLeu_BaLyEn_6 | 108 | 113 | PF01217 | 0.670 |
| TRG_ENDOCYTIC_2 | 94 | 97 | PF00928 | 0.669 |
| TRG_ER_diArg_1 | 11 | 13 | PF00400 | 0.708 |
| TRG_ER_diArg_1 | 159 | 161 | PF00400 | 0.716 |
| TRG_ER_diArg_1 | 167 | 169 | PF00400 | 0.601 |
| TRG_ER_diArg_1 | 42 | 45 | PF00400 | 0.721 |
| TRG_Pf-PMV_PEXEL_1 | 29 | 34 | PF00026 | 0.433 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A3Q8IJZ2 | Leishmania donovani | 88% | 67% |
| A4HY70 | Leishmania infantum | 89% | 67% |
| Q4QDH3 | Leishmania major | 88% | 100% |